These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 8998183)

  • 1. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
    Linderholm B; Grankvist K; Wilking N; Johansson M; Tavelin B; Henriksson R
    J Clin Oncol; 2000 Apr; 18(7):1423-31. PubMed ID: 10735889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of vascular endothelial growth factor in breast cancer.
    Gasparini G
    Oncologist; 2000; 5 Suppl 1():37-44. PubMed ID: 10804090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
    Linderholm B; Tavelin B; Grankvist K; Henriksson R
    J Clin Oncol; 1998 Sep; 16(9):3121-8. PubMed ID: 9738584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival.
    Obermair A; Kucera E; Mayerhofer K; Speiser P; Seifert M; Czerwenka K; Kaider A; Leodolter S; Kainz C; Zeillinger R
    Int J Cancer; 1997 Aug; 74(4):455-8. PubMed ID: 9291439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
    Linderholm B; Tavelin B; Grankvist K; Henriksson R
    Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
    Manders P; Beex LV; Tjan-Heijnen VC; Geurts-Moespot J; Van Tienoven TH; Foekens JA; Sweep CG
    Br J Cancer; 2002 Sep; 87(7):772-8. PubMed ID: 12232762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
    Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
    Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
    Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
    Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.
    Smith BD; Smith GL; Carter D; Sasaki CT; Haffty BG
    J Clin Oncol; 2000 May; 18(10):2046-52. PubMed ID: 10811669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma.
    Toi M; Gion M; Saji H; Asano M; Dittadi R; Gilberti S; Locopo N; Gasparini G
    Int J Oncol; 1999 Dec; 15(6):1169-75. PubMed ID: 10568824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor angiogenesis in node-negative breast carcinoma].
    Li HJ; Jing J; Zhao YB; Zhu JQ; Zhang SY; Shi ZD
    Ai Zheng; 2002 Jan; 21(1):75-8. PubMed ID: 12500403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
    Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
    Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
    Eppenberger U; Kueng W; Schlaeppi JM; Roesel JL; Benz C; Mueller H; Matter A; Zuber M; Luescher K; Litschgi M; Schmitt M; Foekens JA; Eppenberger-Castori S
    J Clin Oncol; 1998 Sep; 16(9):3129-36. PubMed ID: 9738585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.
    Toi M; Bando H; Ogawa T; Muta M; Hornig C; Weich HA
    Int J Cancer; 2002 Mar; 98(1):14-8. PubMed ID: 11857378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.